Christopher Chang, M.D., Ph.D., M.B.A.
Professor
To see if Christopher Chang is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
Lawrence J. Ellison Ambulatory Care Center
Allergy/Rheumatology Clinic
4860 Y St.
Sacramento, CA 95817
Phone: 916-734-2737
Additional Numbers
Physician Referrals
Clinical Interests
Dr. Christopher Chang is an Allergist/Immunologist and a Volunteer Clinical Faculty with the Division of Rheumatology, Allergy and Clinical Immunology. His interests are wide ranging, encompassing primary immunodeficiency diseases (PIDD), Immunodysregulation syndromes, Autoimmune diseases, Mast cell diseases, Food allergy, Epigenetics and Integrative Medicine. He is the Editor-in-Chief of the Journal of Evidence-Based Integrative Medicine, Co-editor of the Journal of Translational Autoimmunity and Associated Editor of Clinical Reviews in Allergy and Immunology.
Research/Academic Interests
Dr. Chang's research and academic interests include immunodysregulatory syndromes, autoimmune diseases, primary immunodeficiencies, food allergy, mast cell disorders, epigenetics and integrative medicine.
Division
Rheumatology, Allergy and Clinical Immunology
Undergraduate School
B.Sc., Georgetown University, Washington DC 1981
Medical School
M.D., Georgetown University School of Medicine, Washington DC 1985
Other School
Ph.D., Chemistry, Georgetown University, Washington DC 1989
Other School
M.B.A., Business Administration, Temple University, Philadelphia PA 2014
Internship
Pediatrics, Children's Hospital of Los Angeles, Los Angeles CA 1986-1987
Residency
Pediatrics, Children's Hospital of Los Angeles, Los Angeles CA 1987-1989
Fellowship
Allergy and Immunology, UC Davis, Davis CA 1991-1993
25 years of Volunteer Faculty - AAAAI, 2018
Que Y, Hu C, Wan K, Hu P, Wang R, Luo J, Li T, Ping R, Hu Q, Sun Y, Wu X, Tu L, Du Y, Chang C, Xu G. Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality. Int Rev Immunol. 2021 Feb 22:1-14. doi:10.1080/08830185.2021.1884248. Epub ahead of print. PMID:33616462.
Chang C, McDonnell P, Gershwin ME. Complex regional pain syndrome - Autoimmune or functional neurologic syndrome. J Transl Autoimmun. 2020 Dec 24;4:100080. doi:10.1016/j.jtauto.2020.100080. PMID:33490941.
Islam M, Chang C, Gershwin ME. Ehlers-Danlos Syndrome: Immunologic contrasts and connective tissue comparisons. J Transl Autoimmun. 2020 Dec 20;4:100077. doi:10.1016/j.jtauto.2020.100077. PMID:33437956.
Jiang J, Zhao M, Chang C, Wu H, Lu Q. Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases. Clin Rev Allergy Immunol. 2020 Oct;59(2):248-272. doi:10.1007/s12016-020-08798-2. PMID:32557263.
Du Y, Zhu P, Wang X, Mu M, Li H, Gao Y, Qin X, Wang Y, Zhang Z, Qu G, Xu G, Chang C, Li T, Fang X, Yu S. Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury. J Autoimmun. 2020 Aug;112:102464. doi:10.1016/j.jaut.2020.102464. Epub 2020 May 4. PMID:32381456.
Sun Y, Dong Y, Wang L, Xie H, Li B, Chang C, Wang FS. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoimmun. 2020 Aug;112:102473. doi:10.1016/j.jaut.2020.102473. Epub 2020 Apr 24. PMID:32439209.
Peng F, Tu L, Yang Y, Hu P, Wang R, Hu Q, Cao F, Jiang T, Sun J, Xu G, Chang C. Management and Treatment of COVID-19: The Chinese Experience. Can J Cardiol. 2020 Jun;36(6):915-930. doi:10.1016/j.cjca.2020.04.010. Epub 2020 Apr 17. PMID:32439306.
Yao Y, Ma J, Chang C, Xu T, Gao C, Gershwin ME, Lian Z. Immunobiology of T cells in Sjogren’s syndrome. Clin Rev Allergy Immunol. 2020 May 11. doi:10.1007/s12016-020-08793-7. PMID:32390096.
Chang C, Gershwin ME. Immunodeficiency and Autoimmunity: The goals of the Journal of Translational Autoimmunity. J Transl Autoimmun. 2019 Jan 17;1:100001. doi:10.1016/j.jtauto.2019.01.001. PMID:32743491.